September 2010 Editor's Picks: Products from Alfa Laval and Gems Sensors and Controls - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

September 2010 Editor's Picks: Products from Alfa Laval and Gems Sensors and Controls

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product Alfa Laval
Magnetic mixer enables high yields

Alfa Laval’s (Lund, Sweden) magnetic mixer is designed to provide high yields and reduce operating costs. Magnetic coupling between the impeller and the driving magnets causes the impeller to levitate. As a result, the impeller has no direct contact with axial bearing surfaces. The design allows the unit to continue mixing until a tank is empty, and it helps achieve a validated mix to a lower tank level than other mixers.

The absence of friction and the eight-winged impeller permit the mixer to achieve run rates higher than 750 rpm. These speeds are appropriate for applications that require heavy mixing and vortex. The mixer also is efficient at speeds as low as 5 rpm in applications that require gentle agitation for sensitive products.

Operators do not have to stop the mixer after a batch to begin clean- or steam-in-place cycles. Because cleaning fluid flows over all surfaces freely, operators do not need to submerge the mixer in cleaning solution.


productGems Sensors and Controls
Solenoid valves use little power

The E Series of pneumatic solenoid valves from Gems Sensors and Controls (Plainville, CT) were designed for air and dry-gas applications such as in printing machinery, sorting equipment, automated packaging equipment, and air-monitoring systems. The valves’ power consumption is 0.65 W. The products offer fast response times and high-pressure and high-flow capabilities.

Each unit features a compact, nickel-plated, cylindrical body and coil housing designed for durability and corrosion resistance. The solenoid valves are available in diameters smaller than 0.75 in. and lengths less than 2 in. The units’ seal and O ring options include nitrile, ethylene–propylene rubber, and silicone. They are available in various two- or three-way configurations, including normally open, normally closed, and multipurpose and directional-control three-way models. The E Series valves’ orifice sizes range from .032 to .078 in., and their port configurations include #10-32 straight thread, M5 x 0.8 threads, manifold mount, and bottom under-seat port.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here